These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29636218)

  • 1. Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP
    Healy MP; Allan AC; Bailey K; Billinton A; Chessell IP; Clayton NM; Giblin GMP; Kay MA; Khaznadar T; Michel AD; Naylor A; Price H; Spalding DJ; Stevens DA; Swarbrick ME; Wilson AW
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1892-1896. PubMed ID: 29636218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of a potent and selective EP4 receptor antagonist.
    Schiffler MA; Chandrasekhar S; Fisher MJ; Harvey A; Kuklish SL; Wang XS; Warshawsky AM; York JS; Yu XP
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3176-8. PubMed ID: 26091726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist.
    Maruyama T; Kuwabe SI; Kawanaka Y; Shiraishi T; Shinagawa Y; Sakata K; Seki A; Kishida Y; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Hashimoto S; Kawamura M; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jul; 10(7):2103-10. PubMed ID: 11983506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
    Blanco MJ; Vetman T; Chandrasekhar S; Fisher MJ; Harvey A; Chambers M; Lin C; Mudra D; Oskins J; Wang XS; Yu XP; Warshawsky AM
    Bioorg Med Chem Lett; 2016 Feb; 26(3):931-935. PubMed ID: 26764191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Inflammatory and Neuroprotective Effects of PGE
    Pradhan SS; Salinas K; Garduno AC; Johansson JU; Wang Q; Manning-Bog A; Andreasson KI
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):292-304. PubMed ID: 27734267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of acute rejection by administration of prostaglandin E2 receptor subtype 4 agonist in rat organ transplantation models.
    Okamoto T; Okamoto S; Fujimoto Y; Tabata Y; Uemoto S
    J Surg Res; 2013 Aug; 183(2):852-9. PubMed ID: 23478083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
    Jiang GL; Im WB; Donde Y; Wheeler LA
    J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.
    Yang L; Junmin S; Hong Y; Shuodong W
    Ann Hepatol; 2013; 12(3):479-86. PubMed ID: 23619266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model.
    Cruz Duarte P; St-Jacques B; Ma W
    Exp Neurol; 2012 Apr; 234(2):466-81. PubMed ID: 22309829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors.
    St-Jacques B; Ma W
    Exp Neurol; 2014 Nov; 261():354-66. PubMed ID: 24910202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases.
    Tang EH; Libby P; Vanhoutte PM; Xu A
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):116-23. PubMed ID: 21697732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred recycling pathway by internalized PGE2 EP4 receptor following agonist stimulation in cultured dorsal root ganglion neurons contributes to enhanced EP4 receptor sensitivity.
    St-Jacques B; Ma W
    Neuroscience; 2016 Jun; 326():56-68. PubMed ID: 27060485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered inhibitory function of the E-type prostanoid receptor 4 in eosinophils and monocytes from aspirin-intolerant patients.
    Luschnig P; Frei R; Lang-Loidolt D; Rozsasi A; Tomazic PV; Lippe IT; Schuligoi R; Heinemann A
    Pharmacology; 2014; 94(5-6):280-6. PubMed ID: 25531811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells.
    Akaba T; Komiya K; Suzaki I; Kozaki Y; Tamaoki J; Rubin BK
    Pulm Pharmacol Ther; 2018 Feb; 48():117-123. PubMed ID: 29129801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signalling transduction events involved in agonist-induced PGE2/EP4 receptor externalization in cultured rat dorsal root ganglion neurons.
    Ma W; St-Jacques B
    Eur J Pain; 2018 May; 22(5):845-861. PubMed ID: 29336505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel modified γ-lactam prostanoids as EP4 subtype-selective agonists.
    Kambe T; Maruyama T; Nagase T; Ogawa S; Minamoto C; Sakata K; Maruyama T; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jan; 20(2):702-13. PubMed ID: 22204740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.